Claritev is showing early signs of a turnaround, with revenue and bookings growth supporting a Buy r

Claritev (NYSE: CTEV - Get Free Report) CFO Douglas Garis sold 9,025 shares of the firm's stock in a

The WTC Health Program is a limited federal health care program established under the James Zadroga

MCLEAN, Va.--(BUSINESS WIRE)---- $CTEV #GDIT--Claritev Corporation (NYSE: CTEV), a healthcare techno

Claritev (NYSE: CTEV - Get Free Report) has been assigned an average rating of "Moderate Buy" from t

On September 17, 2026, Claritev Corp (CTEV) shares fell 5.5%, bringing the current price to $31.73.

MCLEAN, Va.--(BUSINESS WIRE)---- $CTEV #CommunityImpact--Claritev Corporation ("Claritev" or the "Co

Claritev Corporation (CTEV) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Tran

MCLEAN, Va.--(BUSINESS WIRE)---- $CTEV #BoardOfDirectors--Claritev Corporation (“Claritev” or the “C

MCLEAN, Va.--(BUSINESS WIRE)---- $CTEV #ClaritevCares--Claritev Corporation (NYSE: CTEV), a healthca

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a hea

Barclays analyst Glen Santangelo maintains Claritev (NYSE:CTEV) with a Overweight and raises the

Claritev Corporation (NYSE: CTEV), a healthcare technology, data, and insights company, today announ

MCLEAN, Va.--(BUSINESS WIRE)---- $CTEV #ClaimsManagement--Claritev Corporation (NYSE: CTEV), a healt

Wells Fargo analyst Stan Berenshteyn maintains Claritev (NYSE:CTEV) with a Equal-Weight and raise

Claritev Corp (NYSE:CTEV) on Friday reported better-than-expected second-quarter financial results a

CTEV reported better-than-expected Q2 results and raised FY26 sales guidance. Analysts maintain Buy

Citigroup analyst Daniel Grosslight maintains Claritev (NYSE:CTEV) with a Buy and raises the pric

Canaccord Genuity analyst Richard Close maintains Claritev (NYSE:CTEV) with a Buy and raises the

Claritev NYSE: CTEV reported second-quarter revenue growth, record bookings and higher cash flow, pr

Claritev Corporation (CTEV) Q2 2026 Earnings Call Transcript

Claritev Corporation (CTEV) came out with a quarterly loss of $3.49 per share versus the Zacks Conse

Claritev (NYSE:CTEV) raises FY2026 sales outlook from $985.000 million-$1.000 billion to $1.000 bill

Claritev (NYSE:CTEV) reported quarterly losses of $(3.49) per share which beat the analyst consensus

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a tec

Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data, and ins

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a tec

Claritev Corporation (NYSE: CTEV), a healthcare technology, data, and insights company focused on ma

MCLEAN, Va.--(BUSINESS WIRE)---- $CTEV #HealthcareAffordability--Claritev Corporation (NYSE: CTEV),

Canaccord Genuity analyst Richard Close maintains Claritev (NYSE:CTEV) with a Buy and raises the

As stated in the Form 8-K filed on May 18, 2026, in August 2024 Claritev Corporation (the "Compa

Canaccord Genuity analyst Richard Close initiates coverage on Claritev (NYSE:CTEV) with a Buy rat

Smart credit team Ares Mgmt bought discounted BDCs aggressively in Q1 2026. They're not guessing

An article published on Thursday, May 14, 2026 alleges that "DOJ launches criminal antitrust pro

Claritev (NYSE:CTEV) raises FY2026 sales outlook from $980.000 million-$1.000 billion to $985.000 mi

Claritev (NYSE:CTEV) reported quarterly losses of $(4.41) per share which missed the analyst consens

Barclays analyst Glen Santangelo initiates coverage on Claritev (NYSE:CTEV) with a Overweight rat

Wells Fargo analyst Stan Berenshteyn maintains Claritev (NYSE:CTEV) with a Equal-Weight and lower

Citigroup analyst Daniel Grosslight maintains Claritev (NYSE:CTEV) with a Buy and lowers the pric

Guggenheim analyst Jason Cassorla maintains Claritev (NYSE:CTEV) with a Buy and lowers the price

Wells Fargo analyst Stan Berenshteyn maintains Claritev (NYSE:CTEV) with a Equal-Weight and lower

Claritev (NYSE:CTEV) reported quarterly losses of $(4.88) per share which missed the analyst consens